MAPKAP kinase 2 (MK2) is required for tumor necrosis factor synthesis. Tristetraprolin (TTP) binds to the 3-untranslated region of tumor necrosis factor mRNA and regulates its fate. We identified in vitro and in vivo phosphorylation sites in TTP using nanoflow high pressure liquid chromatography microelectrospray ionization tandem mass spectrometry and novel methods for direct digestion of TTP bound to affinity matrices (GSHbeads or anti-Myc linked to magnetic beads 
MK2
1 mediates several p38␣,␤ MAP kinase-dependent processes (for a review, see Ref. 1) , demonstrated most clearly by results from targeted disruption of the MK2 gene in mice (2) . MK2 (Ϫ,Ϫ) mice have suppressed stress responses. Cellular studies show deficits in motility, chemotaxis, and cytokine production. Macrophages taken from MK2 (Ϫ,Ϫ) mice exhibit normal TNF mRNA induction in response to endotoxin but do not release TNF protein. Cellular TNF protein was markedly decreased in MK2 (Ϫ,Ϫ) macrophages, suggesting a block in production of TNF from TNF mRNA (2) . TNF expression is regulated both via mRNA stability and translation (3, 4) but is not completely understood.
The p38␣,␤ MAP kinase pathway regulates stability of mRNAs that contain AU-rich elements in their 3Ј-untranslated regions. Examples include TNF, COX-2, interleukin-6, and interleukin-1␤ (4 -6) . Evidence chiefly comes from mRNA stabilization caused by transfection of mutationally activated MEK3/MEK6 or by the addition of agents that activate p38 MAPK and conversely from destabilization caused by the addition of a p38␣,␤ MAP kinase inhibitor. Since p38␣,␤ is required to activate MK2, these experiments do not dissect contributions from MK2. Studies in MK2 (Ϫ,Ϫ) cells suggest that MK2 regulates stability of some cytokine mRNAs (2, 4). Lasa et al. (5) first reported that expression of a mutant of MK2 with constitutive activity stabilized COX-2 mRNA in the presence of SB2035780 and that expression of a kinase-defective MK2 blocked the stabilization induced by activated MEK6, arguing that MK2 is necessary and sufficient to induce stabilization of at least the COX-2 mRNA (5). How MK2 regulates cytokine production post-transcriptionally is unknown. Mahtani et al. (7) reported that tristetraprolin (TTP) is an in vitro substrate for MK2, motivating the detailed studies we describe.
TTP (for a review, see Ref. 8 ) destabilizes class II AU-rich elements and is the prototype for a non-zinc finger class of nucleic acid-binding proteins. Destabilization requires integrity of the TTP tandem Cys 3 His RNA binding domains that coordinate zinc in a disklike structure (9 -11) . TTP-null mice exhibit many defects including inflammatory arthritis and systemic lupus erythematosis-like symptoms attributed to increased production of TNF (12) .
TTP is phosphorylated in cells treated with growth factors or cytokines. Phosphorylation occurs at more than one site evident by the appearance of two distinct slower migrating forms of TTP on gels after stimulation that are reversed by phosphatase treatment (7, 13) . TTP undergoes detectable gel shifts between ϳ1 and 1.5 h, and the shifts persist for several hours (7, 13) . The only reported TTP phosphorylation site is Ser 220 , phosphorylated by ERK2 in vitro (14) . p38␣ also phosphorylates TTP in vitro, but at unresolved sites (13) . Ser 178 mutation in human TTP causes loss of the ability to bind 14-3-3, suggesting that Ser 178 is a phosphorylation site (15) , but the responsible kinase(s) have not been identified.
We studied phosphorylation of TTP by potently active, recombinant MK2⌬3B produced in E. coli as well as in situ phosphorylation of Myc-TTP expressed in cells. We identified two major (Ser 52 and Ser 178 ) and several minor MK2 sites.
Description as major sites reflects abundance of phosphopeptide and estimated stoichiometry in peptides recovered with the methods we describe. Minor sites detected are not excluded as candidates for functionally significant sites. We show that the major sites (Ser 52 and Ser 178 ) phosphorylated by MK2 are phosphorylated in vivo, and their phosphorylation can be altered by manipulating the p38 pathway in vivo. Furthermore, phosphorylation of TTP by MK2 confers the ability to bind 14-3-3 proteins. Phosphorylation(s) of TTP may provide biological switches to regulate its dynamic life cycle and/or its functions to control mRNA stability and translation.
EXPERIMENTAL PROCEDURES
Materials-Several plasmids were generous gifts from colleagues: C. Moroni provided murine TTP in pCDNA3.1/Myc-HisA (16); M. Cobb provided pT7.5-mup38-huMEK4 (17); C. Marshall provided pEF Myc wild type (WT) and kinase-dead (KD) (D207A) huMK2 (18); and M. Gaestel provided pGEX-muMK2⌬3B (19) and pGEX-MK2EE⌬3B (19) . pKH3-hu14-3-3␤ is from our laboratory. Anti-TTP antibodies to the mouse whole protein (13) and human C-terminal peptide (20) were kindly provided by J. Han and W. Rigby, respectively. Commercially acquired reagents were as follows: horseradish peroxidase-linked antigoat antibodies (Santa Cruz Biotechnology, Inc., Santa Cruz, CA); tosylactivated Dynabeads® (Dynal Biotech); ␥-bind Sepharose plus, glutathione-Sepharose 4B, and horseradish peroxidase-linked anti-mouse and anti-rabbit antibodies (Amersham Biosciences); anisomycin, SB203580, and microcystin LR (Calbiochem); and BHK-21 cells and NIH 3T3 (ATCC).
Plasmids for Expression of Active MK2⌬3B-A bicistronic plasmid (pTYB4 His 6 p38␣-HA 1 MEK6EE) was created by moving the coding region of His 6 -tagged WT p38␣ with the ribosomal binding site engineered after the stop codon (17) into the NcoI site of pTYB4 (New England Biolabs). HA-tagged MKK6EE (excised from the pcDNA3 parent vector with NotI and BglII followed by Klenow fill-in) was bluntcloned into the p38-pTYB4 construct at the NruI site. PCR was used to create an isopropyl-1-thio-␤-D-galactopyranoside-inducible MK2 expression vector with a p15A origin of replication (pAC-pET MK2⌬3B), similar in overall strategy to construction of pAC-pET RSK2CTD (21) . pAC-pET MK2⌬3B expresses a GST-MK2⌬3B fusion protein having an intervening 70-amino acid leader polypeptide containing His 6 and S tags, in addition to thrombin and enterokinase cleavage sites. All constructs were verified by sequencing.
Protein Production and Purification-BL21 E. coli were transformed with pAC-pET MK2⌬3B with or without pTYB4 His 6 38␣-HA 1 MEK6EE using appropriate antibiotic selections. Transformed cells were grown and induced, lysates were prepared, and proteins were purified as described (21) . GST-TTP was expressed and purified as in Ref. 22 . Purified proteins were quantified with the Bio-Rad Protein Assay™ and with SDS-PAGE analysis. Phosphocellulose paper assays were used to monitor kinase activity of the purified GST or His 6 -tagged proteins. The kinase reactions contained (final, in 40 l) 25 mM HEPES, pH 7.4, 5 mM ␤-glycerophosphate, 100 mM NaCl, 2 mM dithiothreitol, 0.25 mg/ml bovine serum albumin, 10 mM MgCl 2 , 50 M [␥-32 P]ATP (ϳ4000 cpm/ pmol), 50 M peptide substrate and were incubated at 30°C for 15 min.
TTP Phosphorylation-Reactions to phosphorylate TTP in vitro for site identification by MS/MS (see below) used the same kinase mixture minus [␥-32 P]ATP and usually omitted bovine serum albumin. GST-TTP (2 g in a 20-l final volume) was phosphorylated with 60 ng of MK2⌬3B for 1 h (30°C). A parallel reaction was always performed that included [␥-
32 P]ATP. Initially, in vitro kinase reactions were stopped with sample buffer and run on 4 -20% gradient minigels. Phosphorylation of TTP could also be visualized by gel shift on minigels when separation times were extended so as to run lower molecular weight species off the gel. Details are provided in the figure legends.
Cell Culture, Transfection, and Lysates-NIH 3T3 cells were grown at 37°C with 5% CO 2 in Dulbecco's modified Eagle's medium supplemented with 10% newborn calf serum. BHK cells were grown similarly, substituting 5% fetal bovine serum for calf serum. Cells were transfected using LipofectAMINE 2000 (Invitrogen) under normal serum conditions, essentially as directed by the manufacturer using 32 g of DNA/15-cm dish (16 g of TTP and either 16 g of MK2 or pCDNA3.1 plasmids). Post-transfection (ϳ24 h), the cells were treated as described in the figure legends. Cell lysates were made as described (23) in 50 mM Tris, pH 8, at 4°C, 50 mM NaCl, 1% Nonidet P-40, 0.5% Triton X-100, 1.5 mM MgCl 2 , 10 g/ml each of leupeptin and aprotinin, 1 M PefaBlock (Roche Applied Science), 200 M Na 3 VO 4 , and 1 M microcystin LR. The lysates were either processed immediately or quick frozen in liquid N 2 for later use.
Immunoprecipitation Using Magnetic Beads-Tosylated Dynabeads® (Dynal Biotech) were covalently attached to pure monoclonal Myc antibody as directed by the manufacturer. Conjugated anti-Myc IgG beads (1 ϫ 10 8 of Dynabeads®) were incubated with cleared cellular lysates for 2 h. After incubation, the beads were magnetically concentrated, and the lysate was removed. The beads were washed three times with PBS (Invitrogen) or for higher stringency once with PBS, twice with PBS containing 0.1 M NaCl, and once with PBS. A portion of the immunoprecipitate was taken for Western blot analysis, and the remainder was washed three times with 0.1 M NH 4 HCO 3 . These NH 4 HCO 3 -washed samples were then subjected to digestion and MS/MS analysis (see below).
Sample Preparation for Analysis with Mass Spectrometry-After experimentation with gel-based methods that were found to be problematic (see "Results" and "Discussion"), we devised a new scheme to be termed "on-beads" digestion. Kinase reactions were terminated by adding cold GSH-Sepharose beads (20 l of a 1:1 slurry), placing the tubes on ice, and washing several times with cold PBS to remove ATP (necessary for immobilized metal affinity chromatography (IMAC)). ATP removal was monitored for sufficiency by following the loss of 32 P from a parallel hot reaction. Then the beads were washed three times with 100 mM NH 4 HCO 3 and resuspended in 50 l. Bound TTP was reduced with dithiothreitol (5 mM final, for 1 h at 51°C) followed by iodoacetamide alkylation (15 mM final, 45 min at room temperature, dark). Sequencing grade trypsin (Promega, Madison, WI) was then added (1:20 ratio) with agitation for 12 h at room temperature. The beads were pelleted, and the supernatant was transferred to a new tube, where acetic acid was used to lower the pH to 3.5. To generate samples for in vivo phosphorylation, the above on-beads digestion procedure was repeated for the TTP immmunoprecipitated with Dynabeads®, except sample reduction and alkylation were omitted (C18) to minimize antibody digestion. Also, the digestion time was reduced to 6 h for the same reason.
Mass Spectrometry-The samples were analyzed by reverse phase nanoflow HPLC micro-ESI tandem mass spectrometry on a ThermoFinnigan LCQ™ Deca or XP ion trap (San Jose, CA) operating in either data-dependent or targeted mode. IMAC was performed according to Ref. 24 , except the peptides were not reacted to form methyl esters, and the elution was done with 7 l of 500 mM ascorbic acid. A gradient consisting of 0 -60% B in 50 min, 60 -100% B in 10 min (A ϭ 100 mM acetic acid (Sigma) in water, B ϭ 70% acetonitrile (Mallinkrodt), 100 mM acetic acid in water) was used to elute peptides from the reverse phase column to the mass spectrometer through an integrated electrospray emitter tip with a flow rate of ϳ60 nl/min. Spectra were acquired with the instrument operating in the data-dependent mode throughout the HPLC gradient. In this mode, every ϳ10 s, the instrument cycled through acquisition of a full-scan mass spectrum and five MS/MS spectra (3-Da window; precursor m/z Ϯ1.5 Da, collision energy set to 35%, dynamic exclusion time of 1 min) recorded sequentially on the five most abundant ions present in the initial MS scan. For the in vivo KD and WT MK2 samples, analysis was performed in the data-dependent mode and run in duplicate. Because this sample was more complex than the in vitro sample, the gradient was changed to 0 -15% B in 7 min, 15-25% B in 20 min, 25-60% B in 35 min, and 60 -100% B in 10 min. This allowed for better resolution of the TTP peptides. In addition, these particular in vivo samples were subjected to a timesegmented targeted analysis in order to obtain the most data points per peptide peak of interest. Four peptides and their corresponding phosphorylated forms were chosen for this analysis. In targeted mode, the instrument was instructed prior to the run to repeat a cycle consisting of a full MS scan followed by a targeted MS/MS scan of the (M ϩ 2H) 2ϩ ion for each pair of nonphosphorylated and phosphorylated peptides based on their retention times (collision energy set to 35%) (see Fig. 6C ).
Peptide Identification-All MS/MS spectra acquired were searched against either a GST-or Myc-TTP protein database by using the SE-QUEST algorithm (25) . Search parameters included a differential modification of ϩ80 Da (presence or absence of phosphate) on serine, threonine, or tyrosine and a static modification of ϩ57 Da (alkylated Cys for the in vitro analysis only). All possible enzymatic cleavage sites were considered. Peptide hits were manually confirmed.
Calculations-Estimated stoichiometries were calculated by dividing the sum of the area under the curve from the phosphopeptide in all of its charge states and modified forms by the total peptide signal. In a single sample, this is an approximation, because phosphopeptides and their nonphosphorylated forms generally do not ionize with the same efficiency. In addition, we estimated changes in stoichiometry of site phosphorylation by ratios of the estimated stoichiometries. Provided that this comparison is confined to the same phospho-and dephosphopeptide in the two conditions, we can make direct comparisons of the relative change in stoichiometry between two conditions with greater confidence.
RESULTS

Selective Activation of GST-MK2⌬3B by p38␣ in E. coli-To
activate MK2⌬3B, we created a GST-MK2⌬3B expression plasmid with a p15A origin of replication (see "Experimental Procedures") that would be compatible with the bicistronic vector expressing both constitutively active MEK1 and WT ERK2 (17) . This co-expression system was used previously in our laboratory to activate GST-RSK CTD (21) , and ERK2 has been reported to activate MK2 (26) . For this reason, we co-expressed MK2⌬3B with active ERK2, but this resulted in no activation of MK2⌬3B. The two proteins also showed no detectable interaction, demonstrated by lack of ERK2 retention on the affinity column (Fig. 1A, panels 1-4) .
We designed a new bicistronic plasmid expressing constitutively active HA-MEK6 and WT His-tagged p38␣. When MK2⌬3B is expressed in E. coli with active p38␣ produced from this bicistronic plasmid, the kinase cascade was reconstituted. MK2⌬3B was phosphorylated, demonstrated by reduced mobility of the protein in SDS-PAGE analysis ( Fig. 1, A and B) and increased peptide kinase activity (Fig. 1C) . In contrast to ERK2, p38␣ was retained on the affinity column, and binding to GST-MK2⌬3B was disrupted by washes with 2 M LiCl, consistent with an electrostatic interaction (Fig. 1A , panels 5 and 6). Phosphorylated MK2⌬3B is dramatically more active than the mutant MK2EE⌬3B (Fig. 1C) .
To identify sites in MK2⌬3B whose phosphorylation was induced by p38␣ in E. coli, a tryptic digest of the activated, purified GST-MK2⌬3B was analyzed with liquid chromatography MS/MS. Phosphorylation of two of three Ser/Thr-Pro sites, at Thr 222 , Ser 272 , and Thr 334 in human MK2, are required for activation (26) . Thr 222 is within the activation loop, Ser 272 is located in the C-lobe of the kinase domain (27) , and Thr 334 is adjacent to an autoinhibitory helix. Our analysis showed that the equivalent three sites are phosphorylated on MK2⌬3B activated by p38␣ in E. coli (data not shown). Phosphorylation at the equivalent of Thr 338 , a presumed autophosphorylation site in human MK2 (26) , was also detected in the purified active enzyme. These same sites were not detectably phosphorylated in MK2⌬3B co-expressed with active ERK2 (data not shown).
MK2⌬3B Phosphorylates Recombinant GST-TTP-GST-TTP protein was phosphorylated by MK2⌬3B in a time-dependent manner similarly to the known in vivo substrate HSP27, whereas GST alone was either minimally or not at all phosphorylated ( Fig. 2A ; data not shown). MK2 phosphorylation sites in TTP were initially analyzed using peptides recovered from silver-stained SDS-PAGE bands of phosphorylated TTP (28) . An example of a gel run for this analysis is shown in Fig. 2B . Phosphorylation of TTP causes a mobility shift of TTP that can be resolved with increased electrophoresis. Analyses of TTP from gels were problematic due to multiple phosphorylated bands, co-migration of the most gel-shifted band with bovine serum albumin, and poor recovery that precluded IMAC to identify minor sites.
On-beads Digestion of TTP Increases Both Coverage and Recovery-To resolve these problems, we devised on-beads digestion methodologies of general utility for future MS/MS analyses. We purified the GST-TTP from the kinase reaction with GSH-Sepharose beads. While still bound, TTP was reduced, alkylated, and digested with trypsin. TTP peptides in the supernatant were analyzed by reverse phase and IMAC MS/MS (Fig. 3) . Sample from on-beads digestion was found to have increased protein coverage (70%) compared with the in-gel digested sample (49%). On-beads digestion allows for better protein recovery, eliminates the possibility of selection bias in excision of gel bands, and provides more material for repeated analyses from a given sample.
Ser 52 and Ser 178 Are Major in Vitro Sites for MK2-Reverse phase MS/MS (Fig. 3 ) allowed us to compare m/z intensities for both the unphosphorylated and phosphorylated peptides and to calculate an estimate of the percentage of TTP phosphorylated at a particular residue of interest (Table I ). The ability to enrich for phosphopeptides on an Fe 3ϩ POROS 20 IMAC column (Fig.  3 ) significantly increased our ability to detect phosphopeptides, allowing us to identify four additional in vitro phosphorylation sites. The calculated percentage of phosphorylation from the reverse phase analysis corresponds well with peptide intensity signals from the IMAC analysis. Because these calculations of stoichiometry are semiquantitative, we will describe the TTP residues we have defined as sites of MK2⌬3B phosphorylation as "major" and "minor" phosphosites.
In Table I (30, 31) .
MK2 Phosphorylation of TTP Creates a 14-3-3 Binding Site-If Ser
178 is a phosphorylation site for MK2, MK2 phosphorylation should cause a gain of function for 14-3-3 binding. To test this, GST-TTP was phosphorylated in vitro by either MK2⌬3B or p38␣ and then tested for altered 14-3-3 binding compared with unmodified GST-TTP. As a source, we used BHK cell lysates that either were transfected with 14-3-3␤ (Fig. 4A) or were not transfected (Fig. 4B) . After incubation of phosphorylated TTP with lysate, GSH-Sepharose beads were added to the mixture. After further incubation, the beads were recovered and washed extensively before elution of TTP for analysis by Western blotting with anti-TTP and pan-anti-14-3-3 antibodies. MK2 phosphorylation caused TTP to gel shift. GST-TTP phosphorylated by MK2 bound 14-3-3 proteins from the lysates, including endogenous 14-3-3, whereas in contrast, the unphosphorylated and p38␣-phosphorylated proteins did so only slightly, and only when 14-3-3␤ was overexpressed (Fig.  4A) .
TTP Phosphorylated by MK2 in Vitro Binds RNA-TTP phosphorylated by MK2⌬3B bound a TNF AU-rich element probe (22) to a similar extent as untreated TTP (data not shown). This suggests that phosphorylation of the MK2 sites does not inhibit RNA binding. Similarly, phosphorylation of TTP by ERK, p38, or c-Jun N-terminal kinase did not alter binding of TTP to a different AU-rich element probe (32) .
TTP Is Predominantly Phosphorylated in Growing BHK
Cells-A significant portion of the expressed Myc-TTP in BHK cells is phosphorylated at the 24-h time point ( Fig. 5 ; data not shown). Expressed Myc-TTP was detected in Western blots using two different antibodies, a polyclonal antiserum to recombinant human TTP (left panel) (13) and monoclonal antibody to the Myc tag (right panel). Endogenous TTP in untransfected BHK cells was not detectable. In lysates from these cells and others, we usually observe three TTP bands in different proportions by Western blotting. In BHK cells, the majority of TTP was detected in the band having the slowest mobility (Fig. 5) .
We treated equivalent plates of BHK cells for 1 h with or without 10 M SB203580, a p38␣,␤ inhibitor. SB203580 caused a small but significant downshift, evident by an increase in the fraction of TTP migrating as the middle band (Fig. 5 and data not shown). This result suggests that activation of pathways other than p38␣,␤ are sufficient to induce shifted phosphorylated states of TTP, an expected result, since mitogens induce TTP and TTP phosphorylation (14) . Mitogen and cytokine stimuli may induce phosphorylation of the same or overlapping physiologic sites. Since TTP was predominantly gel-shifted and phosphorylated in BHK cells, we expressed Myc-TTP to generate mass spectrometry samples for identification of in vivo phosphosites on TTP.
On-beads Digestion of TTP Bound to Anti-tag Antibody Enables Direct in Vivo MS/MS Analyses-Our success with onbeads digestion in the in vitro studies led us to devise an on-beads approach of general utility for studying post-translational modifications of proteins in cells. Myc antibody was covalently bound to magnetic Dynabeads®, chosen because the physicochemical properties of the beads decrease nonspecific GST-MK2⌬3B co-expressed with active p38 probed for anti-p38. An electrostatic interaction, disrupted by 2 M LiCl, is observed between MK2 and p38 but not between MK2 and ERK2. B, SDS-PAGE analysis of GST-MK2⌬3B (GST-MK2EE⌬3B) purified either alone or with activated ERK2 or p38, only MK2 expressed with p38 is gel-shifted. C, kinase activity of purified GST-MK2⌬3B proteins using the p81 paper assay with a peptide substrate (KKLNRTLSVA). MK2 activated by p38 has a much greater specific activity in comparison with the mutational activated protein MK2EE⌬3B. Results are representative of at least two independent experiments.
FIG. 2. Activated MK2 phosphorylates TTP in vitro.
A, kinase assays were analyzed by SDS-PAGE, and incorporation of 32 P into the substrates was visualized using a PhosphorImager. Active GST-MK2⌬3B phosphorylates TTP and HSP27. The lower panel is the Coomassie stain of these gels. B, SDS-PAGE analysis (4 -20% gradient) of concentrated GST-TTP (6 g) phosphorylated with activated GST-MK2⌬3B (0.05 g), silver stain (left panel), and PhosphoImage (right panel). Results are indicative of more than three independent experiments.
interactions. The antibody-linked beads were used to immunoprecipitate Myc-tagged TTP from transfected BHK cells. Then, after extensive washing with PBS and 100 mM NH 4 HCO 3 , the antibody-bound protein was subjected to trypsin digestion without reduction and alkylation in order to minimize digestion of the Myc antibody. To determine whether the p38 pathway was contributing to phosphorylation of the major MK2 phosphosites in BHK cells, we treated transfected cells in parallel with the p38␣,␤ inhibitor. SB203580 caused a small decrease in phosphorylation of Ser 178 in Myc-TTP (Fig. 5 ) (the Ser 52 site was not well resolved in these analyses; data not shown), consistent with the small decrease in the fraction gel-shifted. These results necessitated finding a suitable cell line in which expressed TTP was less extensively phosphorylated so that phosphorylation of TTP might be induced by experimental manipulation of the p38 pathways.
Identification of TTP Phosphosites in BHK Cells
TTP was less extensively phosphorylated in both RAW 264.7 macrophages and NIH 3T3 cells (data not shown). 3T3 cells transfected well enough to provide sufficient Myc-TTP, and RAW cells did not. BHK cells were transfected and maintained in complete medium containing fetal bovine serum. Twentyfour h post-transfection, 3T3 as well as BHK cells were normal in appearance without evidence of apoptosis. Apoptosis occurs to a variable but significant extent when some cell lines, such as 3T3 cells (BHK cells were not studied), are transfected with TTP constructs using different conditions that include removal of serum for 6 h (33, 34). Continued maintenance in media with fetal bovine serum may be important in avoiding apoptosis but was not studied here. 52 and Ser 178 were the major phosphosites in 3T3 cells (data not shown). We also pursued peptides of interest more aggressively, by operating the ion trap in targeted mode (Fig. 6C) 52 and Ser 178 Phosphorylation-As a test of p38 pathway responsiveness, we treated cells with or without anisomycin, which is known to activate p38␣ and MK2 (35) . In addition, 3T3 cells were co-transfected with TTP and KD or WT MK2 plasmids. Treatment with anisomycin resulted in increased phosphorylation at Ser 52 and Ser 178 (Fig. 6A) . Co-expression of WT MK2 with TTP resulted in a clear increase of phosphorylation (Fig. 6B) . The data obtained by averaging all three analyses as compared with the targeted analysis alone produced very similar results. The KD construct did not act as a dominant negative, as observed in other systems (36) . We conclude that MK2 does phosphorylate Ser 52 and Ser 178 in vivo, but our results do not rule out the possibility that these sites may also be substrates for other kinases. 52 and Ser 178 for generation of phosphorylated forms with reduced electrophoretic mobility, we made the double mutant. In cycling BHK cells, S52A/S178A TTP has reduced electrophoretic mobility similar to wild type TTP (Fig. 6E) and Ser 264 ) we identified in vitro may be phosphorylated by p38␣, since it is a minor contaminant in our preparations of active MK2. All of these sites are novel excepting Ser 178 previously identified through mutational analysis as a necessary residue for 14-3-3 binding (15) .
S52A/S178A TTP Exhibits Similar Electrophoretic Mobility to TTP-To determine the requirement for Ser
We showed that phosphorylation of TTP by MK2 creates a binding site for 14-3-3 proteins. (In a different pathway, MK2 phosphorylation of the tuberous sclerosis 2 gene product also creates a 14-3-3 binding site and serves as a precedent for our finding (37) .) Recently, a further indication of a regulatory network involving MK2 and 14-3-3 proteins was obtained in a functional proteomics screen to identify MK2 substrates (38) . MK2 interacts with 14-3-3 and phosphorylates the monomer preferentially on a site in the dimer interface, Ser 58 in subsequence GARRSS 58 , causing decreased dimerization. Thus, both TTP and MK2, but not p38␣, are 14-3-3 interactors.
All of the potential MK2 phosphorylation sites identified as in vitro sites are conserved as equivalent sites in mouse, rat, bovine, and human TTP. Of these, only the Ser 178 and Ser 316 sites are present in the closely related human proteins Tis11b/ ERF-1 or Tis11d/ERF2, although sequences around these sites are not completely conserved. TTP, but not Tis11b or Tis11d, shows synergy with TNF to cause apoptosis (15 TTP phosphorylation at the putative MK2 sites was manipulated in vivo both by anisomycin treatment that activates p38␣ and MK2 and by overexpression of MK2. Importantly, increasing cellular WT MK2 was sufficient to induce phosphorylation. KD MK2 failed to induce phosphorylation, demonstrating that the effect of WT MK2 required its kinase activity. KD MK2 did not lower basal phosphorylation, similar to previous results where co-transfection of a similar KD MK2 construct had no detrimental effect on lipopolysaccharide stimulation of TNF production in WT macrophages (36) . Although it is difficult to prove that a phosphorylation in vivo is direct for any kinase/substrate pair, these correlations strongly support our conclusion that MK2 directly phosphorylates TTP in vivo.
MK2 could phosphorylate TTP in either the nuclear or the cytoplasmic compartment or both. MAP kinases p38␣,␤ are activated outside and then enter the nucleus. MK2 is activated in the nucleus and, once activated, may phosphorylate
FIG. 4. GST-TTP phosphorylated in vitro by MK2 interacts with endogenous 14-3-3.
A, GST-TTP (5 g) was incubated in various kinase reactions with or without activated GST-MK2⌬3B, or p38 (0.05 g), and then the reaction was combined with BHK lysates transfected with 14-3-3. After incubation, the GST-TTP was bound to GSH-Sepharose beads, which were washed and then analyzed by SDS-PAGE for interacting proteins. B, GST-TTP was treated as in A but pretreated with or without SB203580 (10 M), and the BHK cells used to make the lysates were not transfected with 14-3-3, so only endogenous protein was detected. Results are representative of four independent experiments. MK2 may not be the only kinase phosphorylating TTP at the putative MK2 sites we identify. MAPKAP kinase 3 and MAP-KAP kinase 5/Prak are closely related to MK2 and are thus candidates. MK2 itself has two forms in mammals, revealed by in-gel kinase assays as p55 and p45 bands (35) , which both become absent in MK2 (Ϫ,Ϫ) macrophages (2) . The origin of these MK2 forms is still unclear, because evidence for cDNAs in expressed sequence tag databases that could correspond to the shorter form identified biochemically is rare (36) . In addition, kinases phosphorylating MK2 sites in vivo could include kinases in the ERK pathways.
Novel Procedure for Obtaining Mass Spectrometry Samples-So far as we are aware, we are the first to utilize direct digestion of protein samples bound to affinity purification matrices, either GSH-Sepharose beads or Myc antibody linked to magnetic Dynabead®, to generate peptides for liquid chromatography MS/MS analysis. In both cases, digestion directly from the beads was an efficient way of producing sample, with a considerable increase in recovery that provided sufficient peptides for multiple analyses (data-dependent or targeted) and with different types of chromatography (reverse phase or IMAC) from a small amount of protein. We phosphorylated 2 g of TTP and could identify all of the sites from a single on-beads digest using only 10% of the material. In addition, the ability to analyze a protein purified from a crude lysate after on-beads digestion should find immediate applications. Many signaling proteins of importance can be expressed in a functional form as GST fusions, allowing for direct application of on-beads digestion after reduction and alkylation of the recovered protein. These methods are applicable to other affinity reagents such as Ni 2ϩ -nitrilotriacetic acid beads for His-tagged proteins, 2 maltose-bound beads for maltose-binding proteintagged proteins, and others (40) .
It is important to note that the approach we used to minimize antibody contamination of the in vivo sample (eliminating both reduction and alkylation of the sample) can produce altered cleavage patterns of a protein and is a potential cause for reduced protein coverage. This is a potential limitation, depending on the targeted protein. Protein interactors, if still present, could also reduce the extent of cleavage. This is offset by the improved recovery of peptides by avoiding gels and by the practicality for studying in vivo phosphorylations by minor alteration of generally available immunoprecipitation protocols. Bosworth (42) , depending on the stimulus. The same pathways also induce mRNAs containing AU-rich elements that are targets for TTP. In particular, lipopolysaccharide causes p38-dependent induction of TNF and TTP mRNAs (43) , but with differential regulation. TTP mRNA levels increase more rapidly, peaking at ϳ1 h and declining more rapidly thereafter, whereas levels of TNF mRNA peak at ϳ2 h and decline more gradually over the next 2-10 h (13, 43, 44) . Once translated, TTP protein may localize to the nucleus (15, 45, 46) , the cytoplasm (47, 48), or both (48, 49) . Leptomycin causes TTP to accumulate in the nucleus, proving that TTP shuttles. Induced TTP protein levels are down-regulated within 8 h in human monocytes. The profiles vary with other cell types and stimuli (20) , suggesting that down-regulation is regulated separately from induction.
The established effector function of TTP is to negatively regulate mRNA stability. TTP null mice have increased TNF mRNA and plasma TNF, and TNF mRNA is more stable in TTP (Ϫ,Ϫ) cells than in WT cells. TTP additions to a cell-free system destabilize TNF mRNA by stimulating deadenylation (50) . Interestingly, endogenous TTP sediments with polysomes in sucrose gradients (47) , suggesting an additional unsuspected role for TTP in translation and possibly a positive one, since polysomes usually contain the pool of actively translating mRNA. Confocal microscopy data of endogenous TTP stained with a C-terminal antibody (47) suggest to us a cytoplasmic localization of TTP into macromolecular assemblies. Endogenous TTP is concentrated within unidentified, punctate substructures with more distinct borders in resting cells and within more diffuse and more numerous substructures in stimulated cells. These substructures are reminiscent of stress granules (51) .
TTP phosphorylation could regulate its life cycle as well as its effector functions in nuclear or cytoplasmic compartments. The sites are localized schematically in Fig. 7 . When TTP is nuclear in fibroblasts, its export to the cytosol can be stimulated by mitogens (15, 46) , suggesting involvement of kinase cascades activated by mitogens.
TTP has an active nuclear export sequence (NES) within the first 14 amino acids at the N terminus (48, 49) . A sequence required for nuclear localization was mapped to sequence surrounding the first Cys 3 His RNA binding domain, residues 95-130 in muTTP (48, 49 The N terminus along with tandem Cys 3 His RNA binding domains, but not the C terminus, are required for induction of apoptosis caused by expression of TTP (34) . The N terminus is not required to bind mRNA or to destabilize mRNA either in cells or in cell-free assays (50) . Thus, the requirement for the N-terminal domain could be confined to regulation of import/ export, but the role of the N terminus might also include modulation of effector functions. These may be regulated by N-terminal phosphorylations we describe. The N terminus (amino acids 1-100 in muTTP) fused to GAL4 DNA has apparent transactivating activity in PC12 cells, which is inhibitable by phorbol ester (42) . Observed transactivating functions of TTP in macrophages are also altered directly or indirectly by p38 kinase cascades. Expression of TTP robustly down-regulates basal luciferase activity from reporters of cytokine genes TNF and interleukin-8, and it decreases relative induction of the same reporters that, in the absence of TTP expression, are markedly activated by lipopolysaccharide (13) . Stimulation of p38␣,␤ with lipopolysaccharide blocks suppression, and suppression is blocked by p38␣,␤ inhibition.
Major phosphosite Ser 178 is in the C-terminal domain. Phosphorylation of Ser 178 by MK2 may increase TTP levels in the cytoplasmic compartment following activation of the p38 pathway. Ser 178 is not required for mitogen-stimulated export of TTP from the nucleus but is required for 14-3-3 binding. Coexpression of TTP with 14-3-3␤ increased the level of cytoplasmic TTP (15) . Ser 178 is not required for TTP effector function, assayed by the ability of S178A TTP to induce apoptosis.
Currently, we do not know whether phosphorylation impacts the effector activity of TTP as opposed to its life cycle, but phosphorylation could change protein/protein interactions that facilitate deadenylation activity. Multienzyme complexes coordinate what happens at the 5Ј and 3Ј ends of mRNA (52) . MK2 has also been shown to phosphorylate poly(A)-binding protein 1 (53) and heterogeneous nuclear ribonucleoprotein AO (54) . If TTP has a different function that favors or is permissive for translation of cytokine, this would have to have a biologic switch. The major block in TNF production in MK2 (Ϫ,Ϫ) cells is translation not stability of mRNA (4) . In TTP (Ϫ,Ϫ) mice, TNF is overproduced. Thus, as a hypothesis, phosphorylation of TTP at an N-terminal site (Ser 52 , Ser 58 ) or Ser 105 in the nucleus could silence the NLS and/or enhance the NES activity, causing export of TTP. Phosphorylation of Ser 178 could increase its concentration or dwell time or bring another protein to it via the other pocket of bound bifunctional 14-3-3, provided its other pocket does not bind internally to another phosphosite in TTP. Loss of TTP does not block translation. If MK2 regulates translation in part by TTP phosphorylation, TTP should be a repressor of translation when dephosphorylated and an activator of (or neutral to) translation when phosphorylated.
